<DOC>
	<DOCNO>NCT00657865</DOCNO>
	<brief_summary>This project investigate effect ACE-inhibition cellular metabolism gene expression profile human muscle tissue , obtain biopsy prior ramipril intake . This contribute understand pathomechanisms involve diabetes clinical effect ACE-inhibition patient diabetes/metabolic syndrome .</brief_summary>
	<brief_title>Gene Expression Profiling Skeletal Muscle Healthy Subjects Treated With Ramipril</brief_title>
	<detailed_description />
	<mesh_term>Ramipril</mesh_term>
	<criteria>Male Healthy define absence relevant disease Caucasian Aged 1845 year BMI : 1828 kg/m2 Signed informed consent Blood pressure 110/45 &lt; 140/90 ( twice screen ) History renal artery stenosis angioneurotic edema psoriasis relevant renal disease RR screen &lt; 110/45 mmHg . Diabetes , history hypertension , RR &gt; 140/90 screening , cardiovascular disease Known Diabetes mellitus parent HIV Hepatitis B/C positive virology Allergy hypersensitivity ACEinhibitors / ramipril xylocain Contraindications use drug accord SmPC , history angioedema Any drug intake 3 week prior first study day History excessive bleeding tendency / hemophilia Presence relevant illness within last 3 week Suspected noncompliance study instruction lifestyle requirement Alcohol drug abuse Blood/Plasma donation within 4 week prior study day Previous exposure antihypertensive drug , ACEinhibitors , particular ramipril Current smoking ( quantity ) , ( least 6 month nonsmoking require )</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2011</verification_date>
</DOC>